Bloomberg Businessweek cover image

Pfizer’s Second Gut Punch Shows Pitfalls of Weight-Loss Pills

Bloomberg Businessweek

00:00

Introduction

A discussion on Pfizer's decision to drop the development of a twice daily version of its obesity pill and the challenges of developing a weight loss drug, with insights from a Bloomberg News Health reporter.

Play episode from 00:00
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app